Caplin Point Laboratories Ltd Financials
Company Logo

Caplin Point Laboratories Ltd Financial Statement

Caplin Point Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue250.94
Operating Expense109.77
Net Profit105.74
Net Profit Margin42.14
Earning Per Share13.92
EBIDTA141.40
Effective Tax Rate20.65
Invest in Caplin Point Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Caplin Point Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual625.09
Operating Expenses Annual338.01
Operating Profit Annual392.92
Interest Annual0.10
Depreciation25.96
Net Profit Annual283.71
Tax Annual82.03

Caplin Point Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning122.02
Cash Flow from Operations111.01
Cash Flow from Investing-118.13
Cash Flow from Financing-34.26
Cash Flow at the End80.64

Caplin Point Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)62.86
PBIT Margin (%)58.53
PBT Margin (%)-526.73
Net PROFIT Margin (%)45.39
Return On Networth / Equity (%)22.43
Return On Networth /Employed (%)28.84
Return On Assets (%)22.24
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)0.49

Caplin Point Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual165.79
Total Current Assets Annual703.10
Non Current Assets Annual819.21
Total Shareholders Funds Annual1,390.15
Total Assets Annual1,522.31

Caplin Point Laboratories Ltd Earning Calls

EPS (INR)

Expected

17.21

Reported

17.22

Surprise

0.06%

Jun 2024

EPS beaten by 0.06%

Mar 2024

EPS beaten by 0.06%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 24, 2024, Caplin Point Laboratories Ltd has a market capitalization of 10,003.81 Cr. Value Research classifies it as a Large-Cap company.
Yes, Caplin Point Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Caplin Point Laboratories Ltd recorded a total revenue of approximately 625.09 Cr marking a significant milestone in the company's financial performance.
Caplin Point Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..
Caplin Point Laboratories Ltd's current PE ratio is 35.26.
Caplin Point Laboratories Ltd's ROCE averaged 26.2% from the FY ending March 2022 to 2024, with a median of 26.2%. It peaked at 26.8% in March 2022, reflecting strong capital efficiency over the period..
Caplin Point Laboratories Ltd's latest EBIT is Rs. 365.84 Cr, surpassing the average EBIT of Rs. 303.17 Cr over the 5 years..